Article
The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Scientific reports - 20 Mar 2020
Ding Xiaoying, Han Xinsheng, Yuan Haozheng, Zhang Yong, Gao Ya
Abstract excerpt
Recent studies showed that peroxisome proliferator-activated receptors (PPARs) had effects on the progression of multiple tumors, but the role of PPARD and PPARG in glioma remains poorly understand. We conducted a case-control study to investigate the association of polymorphisms in PPARD and PPARG with glioma risk and prognosis in the Chinese Han population. Seven polymorphisms (PPARD: rs2016520, rs67056409,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
